Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
Stopped This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07007702.
Conditions
Interventions
- DRUG: Thealoz Total® Eye Drops, Laboratoires Thea, Clermont Ferrand, France
Sponsor
Medical University of Vienna